Cellular immune responses to recombinant Plasmodium vivax tryptophan-rich antigen (PvTRAg) among individuals exposed to vivax malaria

Authors: ALAM, M. T.¹; BORA, H.¹; MITTRA, P.¹; SINGH, N.²; SHARMA, Y. D.¹

Source: Parasite Immunology, Volume 30, Numbers 6-7, June/July 2008 , pp. 379-383(5)

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

SUMMARY

Plasmodium vivax, the most widespread species of human malaria parasite responsible for 70-80 million cases each year requires a vaccine. In recent years, many potential vaccine candidate antigens have been identified from P. vivax including PvTRAg. We describe here cellular immune response to recombinant PvTRAg expressed in Escherichia coli. The in vitro stimulation of PBMCs derived from P. vivax-exposed individuals (n = 16) showed strong proliferative response (SI > 2·2) to PvTRAg as compared to PBMCs from normal healthy controls (n = 8). Although both Th1 (IFN-γ, TNF-α and IL-12) and Th2 (IL-4 and IL-10) cytokines were secreted by the PBMCs of the P. vivax-exposed individuals in response to PvTRAg, the overall response was more inclined towards Th2. In conclusion, recombinant PvTRAg was found to elicit strong cellular immune response among the P. vivax-exposed individuals.

Keywords: cellular immune responses; malaria vaccine; Plasmodium vivax; Tryptophan-rich antigen; Th1/Th2 cytokines

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-3024.2008.01033.x

Affiliations: 1: Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, India, 2: Regional Medical Research Centre for Tribes, Jabalpur, Madhya Pradesh, India

Publication date: 2008-06-01